Miller SD - Search Results

1

ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis.

Hussien Y, Podojil JR, Robinson AP, Lee AS, Miller SD, Popko B. Hussien Y, et al. Among authors: miller sd. J Neurosci. 2015 Dec 2;35(48):15921-33. doi: 10.1523/JNEUROSCI.0693-15.2015. J Neurosci. 2015. PMID: 26631473 Free PMC article.

2

Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein.

McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Picha KS, Miller SD. McRae BL, et al. Among authors: miller sd. J Neuroimmunol. 1992 Jun;38(3):229-40. doi: 10.1016/0165-5728(92)90016-e. J Neuroimmunol. 1992. PMID: 1376328

3

Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.

Kennedy MK, Tan LJ, Dal Canto MC, Tuohy VK, Lu ZJ, Trotter JL, Miller SD. Kennedy MK, et al. Among authors: miller sd. J Immunol. 1990 Feb 1;144(3):909-15. J Immunol. 1990. PMID: 1688591

4

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.

McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. McRae BL, et al. Among authors: miller sd. J Exp Med. 1995 Jul 1;182(1):75-85. doi: 10.1084/jem.182.1.75. J Exp Med. 1995. PMID: 7540658 Free PMC article.

5

An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.

Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD. Karpus WJ, et al. Among authors: miller sd. J Immunol. 1995 Nov 15;155(10):5003-10. J Immunol. 1995. PMID: 7594507

6

Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.

Karpus WJ, Kennedy KJ, Smith WS, Miller SD. Karpus WJ, et al. Among authors: miller sd. J Neurosci Res. 1996 Aug 15;45(4):410-23. doi: 10.1002/(SICI)1097-4547(19960815)45:4<410::AID-JNR10>3.0.CO;2-4. J Neurosci Res. 1996. PMID: 8872901

7

Degenerate antigen recognition by CD4+ effector T cells in experimental autoimmune encephalomyelitis.

McRae BL, Karandikar NJ, Miller SD. McRae BL, et al. Among authors: miller sd. J Neuroimmunol. 1997 May;75(1-2):156-62. doi: 10.1016/s0165-5728(97)00014-3. J Neuroimmunol. 1997. PMID: 9143249

8

Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis: a comparison between oral and peripheral tolerance.

Kennedy KJ, Smith WS, Miller SD, Karpus WJ. Kennedy KJ, et al. Among authors: miller sd. J Immunol. 1997 Jul 15;159(2):1036-44. J Immunol. 1997. PMID: 9218627

9

Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis.

Burt RK, Padilla J, Begolka WS, Canto MC, Miller SD. Burt RK, et al. Among authors: miller sd. Blood. 1998 Apr 1;91(7):2609-16. Blood. 1998. PMID: 9516163 Free article.

10

Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis.

Begolka WS, Miller SD. Begolka WS, et al. Among authors: miller sd. Res Immunol. 1998 Nov-Dec;149(9):771-81; discussion 843-4, 855-60. doi: 10.1016/s0923-2494(99)80004-2. Res Immunol. 1998. PMID: 9923632 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

683 results

Search Page

Filters